Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jul;28(3):193-6.
doi: 10.1111/j.1574-695X.2000.tb01476.x.

Modulation of Lymphocyte Proliferative Responses by a Canine Lyme Disease Vaccine of Recombinant Outer Surface Protein A (OspA)

Affiliations
Free article

Modulation of Lymphocyte Proliferative Responses by a Canine Lyme Disease Vaccine of Recombinant Outer Surface Protein A (OspA)

J W Chiao et al. FEMS Immunol Med Microbiol. .
Free article

Abstract

The modulation of human lymphocyte proliferative responses was demonstrated with a recombinant outer surface protein A (OspA) vaccine preparation for the prevention of Borrelia burgdorferi infection. After exposure to either the unaltered vaccine preparation or OspA prepared in saline, normal lymphocyte responses to the mitogens concanavalin A, phytohemagglutinin-M or pokeweed mitogen, or the antigen BCG were consistently reduced. Whole cell extracts of B. burgdorferi also modulated immune responses but required a much greater quantity of protein than needed for the OspA preparation. The magnitude of modulation was directly dependent on the quantity of OspA. OspA interferes with the response of lymphocytes to proliferative stimuli including a blocking of cell cycle phase progression. Future studies designed to delete the particular region or component of the OspA molecule responsible for this effect may lead to improved vaccine preparations.

Similar articles

See all similar articles

Cited by 1 article

MeSH terms

LinkOut - more resources

Feedback